United States - English - NLM (National Library of Medicine)

stat rx usa llc - beclomethasone dipropionate monohydrate (unii: 4h7l9ai22i) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate monohydrate 42 ug - beconase aq nasal spray is indicated for the relief of the symptoms of seasonal or perennial allergic and nonallergic (vasomotor) rhinitis. results from 2 clinical trials have shown that significant symptomatic relief was obtained within 3 days. however, symptomatic relief may not occur in some patients for as long as 2 weeks. beconase aq nasal spray should not be continued beyond 3 weeks in the absence of significant symptomatic improvement. beconase aq nasal spray should not be used in the presence of untreated localized infection involving the nasal mucosa. beconase aq nasal spray is also indicated for the prevention of recurrence of nasal polyps following surgical removal. clinical studies have shown that treatment of the symptoms associated with nasal polyps may have to be continued for several weeks or more before a therapeutic result can be fully assessed. recurrence of symptoms due to polyps can occur after stopping treatment, depending on the severity of the disease. hypersensitivity to an

United States - English - NLM (National Library of Medicine)

glaxosmithkline llc - beclomethasone dipropionate monohydrate (unii: 4h7l9ai22i) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 42 ug - beconase aq nasal spray is indicated for the relief of the symptoms of seasonal or perennial allergic and nonallergic (vasomotor) rhinitis. results from 2 clinical trials have shown that significant symptomatic relief was obtained within 3 days. however, symptomatic relief may not occur in some patients for as long as 2 weeks. beconase aq nasal spray should not be continued beyond 3 weeks in the absence of significant symptomatic improvement. beconase aq nasal spray should not be used in the presence of untreated localized infection involving the nasal mucosa. beconase aq nasal spray is also indicated for the prevention of recurrence of nasal polyps following surgical removal. clinical studies have shown that treatment of the symptoms associated with nasal polyps may have to be continued for several weeks or more before a therapeutic result can be fully assessed. recurrence of symptoms due to polyps can occur after stopping treatment, depending on the severity of the disease. hypersensitivity to any of the in

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

orient europharma (m) sdn bhd - beclomethasone dipropionate; formoterol fumarate dihydrate; glycopyrronium bromide -

Malta - English - Medicines Authority

generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - beclometasone dipropionate - nasal spray, solution - beclometasone dipropionate 50 µg - nasal preparations

Canada - English - Health Canada

apotex inc - beclomethasone dipropionate - suspension - 50mcg - beclomethasone dipropionate 50mcg - corticosteroids

Canada - English - Health Canada

apotex inc - beclomethasone dipropionate - suspension - 50mcg - beclomethasone dipropionate 50mcg - corticosteroids

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glenmark pharmaceuticals (malaysia) sdn. bhd. - beclomethasone dipropionate; salbutamol sulphate -

Canada - English - Health Canada

teva canada limited - beclomethasone dipropionate - metered-dose aerosol - 40mcg - beclomethasone dipropionate 40mcg - corticosteroids

Canada - English - Health Canada

teva canada limited - beclomethasone dipropionate - metered-dose aerosol - 80mcg - beclomethasone dipropionate 80mcg - corticosteroids

United States - English - NLM (National Library of Medicine)

teva respiratory, llc - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 80 ug - qnasl® nasal aerosol is indicated for the treatment of the nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older. qnasl nasal aerosol is contraindicated in patients with a history of hypersensitivity to beclomethasone dipropionate and/or any other qnasl nasal aerosol ingredients [see warnings and precautions (5.3)] . teratogenic effects : pregnancy category c there are no adequate and well-controlled clinical trials in pregnant women treated with qnasl nasal aerosol. beclomethasone dipropionate was teratogenic and embryocidal in the mouse and rabbit although these effects were not observed in rats. qnasl nasal aerosol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. experience with oral corticosteroids since their introduction in pharmacologic, as opposed to physiologic, doses suggests that rodents are more prone to teratogenic effects from corticosteroids than humans. beclomethasone dipropionate ad